Pharmacotherapy for traumatic brain injury: Focus on sympathomimetics

Pharmacology and Therapeutics

Volumn 134, Issue 1, 2012, Pages 1-7

  Young, James A ^a  

^a RUSH UNIVERSITY   (United States)

Author keywords

Amantidine; Dextroamphetamine; Dopamine; Methylphenidate; Modafinil; Rehabilitation

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; AMANTADINE; BRADYKININ RECEPTOR AGONIST; BROMOCRIPTINE; CANNABINOID DERIVATIVE; CYCLOSPORIN; DEXAMPHETAMINE; LEVODOPA; MEMANTINE; METHYLPHENIDATE; MODAFINIL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PLACEBO; PROGESTERONE; TRAXOPRODIL;

DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; DRUG MECHANISM; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; TRAUMATIC BRAIN INJURY;

BRAIN INJURIES; HUMANS; SYMPATHOMIMETICS;

EID: 84857363558     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2011.08.003     Document Type: Review

References (110)

1. S. Al-Adawi, R. Calvanio, A.S.S. Dorvlo, R.E. Costa, J.J. Mello, and C.C. Huynh The effect of methylphenidate on attention in acquired brain injury as record by useful field of view J Appl Res 5 2005 61 72
2. L. Alexander Mild traumatic brain injury: pathophysiology, natural history, and clinical management Neurology 45 1995 1253 1260
3. Army Medicine Traumatic Brain Injury (TBI) Task Force Report www.armymedicine.army.mil/prr/tbitfr.html 2009 (accessed November 14)
4. J.W. Bales, A.K. Wagner, A.E. Kline, and C.E. Dixon Neurosci Biobehav Rev 33 2009 981 1003
5. S. Barbay, and R.J. Nudo The effects of amphetamine on recovery of function in animal models of cerebral injury: a critical appraisal NeuroRehabilitation 25 2009 5 17
6. S. Barbay, E.V. Zoubina, N. Dancause, S.B. Frost, E. Eisner-Janowicz, and A.M. Stowe A single injection of d-amphetamine facilitate improvements in motor training following a focal cortical infarct in squirrel monkeys Neurorehabil Neural Repair 20 2006 455 458
7. K. Beauchamp, H. Mutlak, W.R. Smith, E. Shohami, and P.H. Stahel Pharmacology of traumatic brain injury: where is the "golden bullet"? Mol Med 14 2008 731 740
8. T. Brannan, J. Martinex-Tica, A. DiRocco, and M.D. Yahr Low and high dose bromocriptine have different effects on striatal dopamine release: an in vivo study J Neural Transm Park Dis Dement Sect 6 1993 81 87
9. J.M. Braughler, and J.F. Pregenzer The 21-aminosteroid inhibitors of lipid peroxidation: reactions with lipid peroxyl and phenoxy radicals Free Radic Biol Med 7 1989 125 130
10. E.M. Brecher The Consumers Union Report on Licit and Illicit Drugs http://www.druglibrary.org/schaffer/Library/studies/cu/CU36.html 1972
11. A.W. Brown, B. Bjelke, and K. Fuxe Motor response to amphetamine treatment, task-specific training, and limited motor experience in a postacute animal stroke model Exp Neurol 190 2004 102 108
12. M.J. Buckley The role of the perirhinal cortex and hippocampus in learning, memory and perception Q J Exp Psychol 58 2005 246 268
13. A. Bueno-Nava, S. Montes, P. Delagarza-Montano, A. Alfaro-Rodriguez, A. Ortiz, and R. Gonzalez-Pina Reversal of noradrenergic depletion and lipid peroxidation in the pons after brain injury correlates with motor function recovery in rats Neurosci Lett 443 2008 32 36
14. CDC: Center for Disease Control Interactive data tables http://www.cdc.gov/nchs/health-data-for-all-ages.htm 2005
15. CDC: Center for Disease Control (2006). Traumatic brain injury in the United States: emergency department visits, hospitalization and deaths 2002-2006. From www.cdc.govtraumaticbrain injury/tbi-edu.html
16. A.K. Christman, J.D. Fermo, and J.S. Markowitz Atomoxetine, a novel treatment for attention deficit hyperactivity disorder Pharmocotherapy 24 2004 1020 1036
17. R. Chudasama, F. Nathwani, and T.W. Robbins Amphetamine remediates attentional performance in rats with dorsal prefrontal lesion Brain Res 158 2005 97 107
18. B. Conroy, R. Zorowitz, S.D. Horn, D.K. Ryser, J. Teraoka, and R.J. Smout An exploration of central nervous system medication use and outcomes in stroke rehabilitation Arch Phys Med Rehabil 86 12 Suppl. 2 2005 S73 S81
19. E.A. Crisostomo, P.W. Duncan, M. Propost, D.V. Dawson, and J.N. Davis Evidence that amphetamine with physical therapy promotes recovery of motor function in stroke patients Ann Neurol 23 1988 94 97
20. E. Donnemiller, C. Brenneis, J. Wissel, C. Scherfler, W. Poewe, and G. Riccabona Impaired dopaminergic neurotransmission in patient with traumatic injury: a SPECT study using 123-beta-CIT and1231-IBZM Eur J Nucl Med 27 2000 1410 1414
21. M.M. Dopheide, R.E. Morgan, K.R. Rodvelf, T.R. Schachtman, and D.K. Miller Modafinil evokes striatal [H3] dopamine release and alters the subjective properties of stimulants Eur J Pharm 568 2007 112 123
22. P.E. Empey, P.J. McNamara, B. Young, M.B. Rosbolt, and J. Hatton Cyclosporin A disposition following acute traumatic brain injury J Neurotrauma 23 2006 109 116
23. R.W. Evans, and C.T. Gualtieri Psychostimulant pharmacology in traumatic brain injury J Head Trauma Rehabil 2 1987 29 33
24. D.M. Feeney, and J.C. Baron Diaschisis Stroke 17 1986 817 830
25. D.M. Feeney, and R.L. Sutton Pharmacotherapy for recovery of function after brain injury Crit Rev Neurobiol 3 1987 135 197
26. J.J. Feigenbaum, F. Bergmann, S.A. Richmond, R. Mechoulam, V. Nadler, and Y. Kloog Nonpsychotropic cannabinoid acts as a functional N-methyl-d-aspartate receptor blocker Proc Natl Acad Sci 86 1989 762 764
27. A receptor blockade Neuropsychopharmacology 20 1999 346 356
28. L. Ferraro, K. Fuxe, S. Tanganelli, M.C. Tomasini, F.A. Rambert, and T. Antonelli Differential enhancement of dialysate serotonin levels in distinct brain regions of the awake rate by modafinil: possible relevance for wakefulness and depression J Neurosci Res 68 2002 107 178
29. A. Fontaine, P. Azouvi, P. Remy, B. Bussel, and Y. Samson Functional anatomy of neuropsychological deficits after severe traumatic brain injury Neurology 53 9 1999 1963 1968
30. P.C. Francel Bradykinin and neuronal injury J Neurotrauma 9 Suppl 1 1992 S27 S45
31. R. Gallopin, P.H. Luppi, F.A. Rambert, A. Frydman, and P. Fort Effect of the wake-promoting agent modafinil on sleep-promoting neurons from the ventrolateral preoptic nucleus: an in vitro pharmacologic study Sleep 27 2004 19 25
32. G. Gianutsos, S. Chute, and J.P. Dunn Pharmacological changes in dopaminergic systems induced by long-term administration of amantidine Eur J Pharmaca 110 1985 357 361
33. D.J. Gladstone, C.J. Danells, A. Armesto, W.E. McIlroy, S.J. Graham, and N. Herrmann Physiotherapy coupled with dextroamphetamine for rehabilitation after hemiparetic stroke; a randomized double-blind, placebo-controlled trial Stroke 37 2006 179 185
34. L.B. Goldstein Potential effects of common drugs on stroke recovery Arch Neurol 55 1998 454 456
35. L.B. Goldstein Amphetamine-facilitated poststroke recovery Stroke 30 1999 696 698
36. L.B. Goldstein, and J.N. Davis Physician prescribing patterns after ischemic stroke Neurology 38 1988 1806 1809
37. L.B. Goldstein, and J.N. Davis Restorative neurology. Drugs and recovery following stroke Curr Concepts Cerebrovasc Dis Stoke 25 1990 19 24
38. L.B. Goldstein, D.B. Matchar, J.C. Morgenlander, and J.N. Davis Drugs influence the recovery of fucntion after stroke Stroke 21 1990 179
39. C. Grade, B. Redford, J. Chronstowski, L. Toussaint, and B. Blackwell Methylphenidate in early poststroke recovery: a double-blind, placebo-controlled study Arch Phys Med Rehabil 79 1998 1047 1050
40. J. Grafman, K. Schwab, D. Warden, A. Pridgen, H.R. Brown, and A.M. Salazar Frontal lobe iinjuries, violence and aggression: af report of the Vietman Head Injury Study Neurology 46 1996 1231 1238
41. C.T. Gualtieri Pharmacotherapy and the neurobehavioural sequelae of traumatic brain injury Brain Inj 2 1988 101 129
42. E.D. Hall, P.A. Yonkers, J.M. McCall, and J.M. Braughler Effects of the 21-aminosteroid U74006F on experimental head injury in mice J Neurosurg 68 1988 456 461
43. T.J. Hamilton, B.M. Wheatley, D.B. Sinclair, M. Bachmann, M.E. Larkum, and W.F. Colmers Dopamine modulates synaptic plasticity in dendrites of rat and human dentate granule cells Proc Natl Acad Sci USA 107 42 2010 18185 18190
44. C. Hoffman Catecholoamines, sympathomimetic drugs and adrenergic receptor antagonists J. Hardman, L. Limbird, The Pharmacological Basis of Therapeutics 2001 McGraw-Hill New York
45. C.W. Hoge, H.M. Goldberg, and C.A. Castro Care of war veterans with mild traumatic brain injury-flawed perspectives NEJM 360 2009 1588 1591
46. C.W. Hoge, D. McGurk, J.L. Thomas, A.L. Cox, C.C. Engel, and C.A. Castro Mild traumatic brain injury in U.S. soldiers returning from Iraq N Engl J Med 358 2008 453 463
47. D.A. Hovda, and D.M. Feeney Haloperidol blocks amphetamine induced recovery of binocular depth perception after bilateral visual cortex ablation in cat Proc West Pharmacol Soc 28 1985 209 211
48. S. Hughes, A. Colantonio, P.L. Santaguida, and T. Paton Amantidine to enhance readiness for rehabilitation following severe traumatic brain injury Brain 19 2005 1197 1206
49. T. Ishizuka, M. Murakami, and A. Yamatodani Involvement of central histaminergic systems in modafinil-induced but not methylphenidate-induced increases in locomotor activity in rats Eur J Pharm 578 2007 209 215
50. S. Izenwasser, A.E. Coy, B. Ladenheim, R.J. Loeloff, J.L. Cadet, and D. French Chronic methylphenidate alters locomotor activity and dopamine transporters differently from cocaine Eur J Pharmacol 373 1999 187 193
51. A. Jha, J.A. Weintraub, A. Allshouse, C. Morey, C. Cusick, and J. Kittelson A randomized trial of modafinil for the treatment of fatigue and excessive daytime sleepiness in individuals with chronic traumatic brain injury J Head Trauma Rehabil 23 2008 52 63
52. M. Junpeng, S. Huang, and S. Qin Progesterone for acute traumatic brain injury Cochrane Database Syst Rev 1 2011 CD008409 (Jan 19)
53. P.R. Kaiser, P.O. Valko, E. Werth, J. Thomann, J. Meier, and R. Stocker Modafinil ameliorates excessive daytime sleepiness after traumatic brain injury Neurology 75 2010 1780 1785
54. J. Kaplanski, L. Ding-Zhou, I. Margaill, B. Palmier, D. Pruneau, and M. Plotkine LF 16-0687 Ms, a bradykinin B2 receptor antagonist, reduces brain edema andimproves long-term neurological function recovery after closed head truma in rats J Neurotrauma 19 2002 953 964
55. M.F. Kraus, G.S. Smith, M. Butters, A.J. Donnell, E. Dixon, and C. Yilong Effects of the dopaminergic agent and NMDA receptor antagonist Amantadine on cognitive function, cerebral glucose metabolism and D2 receptor availability in chronic traumatic brain injury: a study using positron emission tomography (PET) Brain Inj 19 2005 471 479
56. M.F. Kraus, R. Susmaras, B.P. Caughlin, C.J. Walker, J.A. Sweeney, and D.M. Little White matter integrity and cognition in chronic traumatic brain injury: a diffusion tensor imaging study Brain 130 2007 2508 2519
57. J. Kreutzer, J. Marwitz, and A. Witol Interrelationships between crime, substance abuse, and aggressive behavior among persons with traumatic brain injury Brain Inj 9 1995 757 768
58. T.W. Langfitt, W.D. Obrist, A. Alavi, R.I. Grossman, R. Zimmerman, and J. Jaggi Computerized tomography, magnetic resonance imaging, and positron emission tomography in the study of brain trauma. Preliminary observations J Neurosurg 64 5 1986 760 767
59. J. Langham, C. Goldfrad, G. Teasdale, D. Shaw, and K. Rowan Calcium channel blockers for acute traumatic brain injury Cochrane Database Syst Rev 2003 CD000565
60. J.A. Langlois, W. Rutland-Brown, and K.E. Thomas Visits, hospitalization, and deaths Atlanta (GA): Centers for disease Control and Prevention, National Center for Injury Traumatic brain injury in the United States: emergency department Prevention and Control 2006
61. N. Lemon, and D. Manahan-Vaughan Dopamine D1/D5 receptors gate the acquisition of novel information through hippocampal long-term potentiation and long-term depression J Neurosci 26 2006 7723 7729
62. L.M. Levy, O. Warr, and D. Attwell Stoiochiometry of the glial glutamate transporter GLT-1 expressed inducibly in a chinese hamster ovary cell line selected for low endogenous Na+ dependent glutamate uptake J Neurosci 18 1998 9620 9628
63. S. Li, W.K. Cullen, R. Anwul, and M.J. Rowan Dopamine-dependent facilitation of LTP induction in hippocampal ca 1 exposure to spatial novelty Nat Neurosci 6 2003 526 531
64. D.J. Loane, and A.I. Faden Neuroprotection for traumatic brain injury: translation challenges and emerging therapeutic strategies Trends Pharmacol Sci 31 2010 596 604
65. D. Long, and J. Young Dexamphetamine treatment in stroke Q J Med 96 2003 673 685
66. A.I. Maas, G. Murray, H. Henney 3rd, N. Kassem, V. Legrand, and M. Mangelus Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomised, placebo-controlled, clinical trial Lancet Neurol 5 2006 38 45
67. A. Marmarou, M. Guy, L. Murphey, F. Roy, L. Layani, and J.P. Combal A single dose, threee arm, placebo-controlled, phase I study of the bradykinin B2 receptro antagonist anatibant (LF16-0687Ms) in patients with severe traumatic brain injury J Neurotruma 22 2005 1444 1455
68. L.F. Marshall, A.I. Maas, S.B. Marshall, A. Bricolo, M. Fearnside, and F. Iannotti A multicenter trial on the efficacy of using tirilazad mesylate in cases of head injury J Neurosurg 89 1998 519 525
69. L. Martinsson, and N.G. Wahlgreen Safety of dexamphetamine in acute ischemic stroke. A randomized, double-blind, controlled dose-escalation trial Stroke 34 2003 475 481
70. L. Martinsson, N.G. Wahlgren, and H.G. Hardemark Amphetamines for improving recovery after stroke. A systematic Cochrane Review Stroke 34 2003 2766 2768
71. T.W. McAllister, L.A. Flashman, M.B. Sparling, and A.J. Saykin Working memory deficits after traumatic brain injury: catecholaminergic mechanisms and prospects for treatment-a review Brain Inj 18 2004 331 350
72. J. McDaid, M.P. Graham, and T.C. Napier Methamphetamine-induced sensitization differentially alters pCREB and delta FosB throughout the limbic circuit of the mammalian brain Mol Pharmacol 70 2009 2064 2074
73. J.M. Meythaler, R.C. Brunner, A. Hohnson, and T.A. Novack Amantadine to improve neurorecovery in traumatic brain injury-associated diffuse axonal injury: a pilot double blind randomized trial J Head Trauma Rehabil 17 2002 300 313
74. E. Naplitano, E. Elovic, and A. Qureshi Pharmacological stimulant treatment of neurocognitive and functional deficits after traumatic and non-traumatic brain injury Med Sci Monit 11 2005 RA212 RA220
75. E.H. Pettus, D.W. Wright, D.G. Stein, and S.W. Hoffman Progesterone treatment inhibits the inflammatory agents that accompany traumatic brain injury Brain Res 1049 2005 112 119
76. Physicians' Desk Reference 2005 Thomson PDR Motvale NJ
77. T. Platz, I.H. Kim, U. Engel, C. Pinkowski, C. Eickhof, and M. Jutzner Amphetamine fails to facilitate motor performance and to enhance motor recovery among stroke patients with mild arm paresis: interim analysis and termination of a double blind, randomised, placebo-controlled trial Restor Neurol Neurosci 23 2005 271 280
78. J.H. Powell, S. Al-Adawi, J. Morgan, and R.J. Greenwood Motivational deficits after brain injury: effects of Bromocriptine in 11 patients J Neurol Neurosurg Psychiatry 60 1996 416 421
79. S.A. Queen, J.F. Chen, and D.M. Feeney d-Amphetamine attenuates decreased cerebral glucose utilization after unilateral sensorimotor cortex contusion in rats Brain Res 777 1997 42 50
80. K.T. Ragnarsson Results of the NIH consensus conference on "Rehabilitation of persons with traumatic brain injury" Restor Neurol Neurosci 20 2002 103 108
81. M. Ramic, A.J. Emerick, M.R. Bollnow, T.E. O'Brien, S. Tsai, and G.L. Kartje Axonal plasticity is associated with motor recovery following amphetamine treatment combined with rehabilitation after brain injury in the adult rat Brain Res 1111 2006 176 186
82. K.W. Rammohan, J.H. Rosenberg, D.J. Lynn, A.M. Blumenfeld, C.P. Pollak, and H.N. Nagaraja Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study JNNP 72 2002 179 183
83. M. Rappport, and K.M. Hall Disability rating scale for severe head trauma: coma to community Arch Phys Med Rehabil 63 1982 118 123
84. R.S. Raumussen, K. Overgaard, E.S. Hildebrandt-Eriksen, and G. Boysen d-amphetamine improves cognitive deficits and physical therapy promotes fine motor rehabilitation in a rat embolic stroke model Acta Neurol Scand 113 2006 189 198
85. W.M. Reid, and R.J. Hamm Post-injury atomoxetine treatment improves cognition following experimental traumatic brain injury J Neurotrauma 25 2008 248 256
86. D.L. Ripley Atomoxetine for individuals with traumatic brain injury J Head Trauma Rehabil 21 2006 85 88
87. E. Sawyer, L.S. Mauro, and M.J. Ohlinger Amantidine enhancement of arousal and cognition after traumatic brain injury Ann Pharmacother 42 2008 247 252
88. W.K. Schiffer, N.D. Volkow, J.S. fowler, D.L. Alexoff, J. Logan, and S.L. Dewey Therapeutic doses of methylphenidate differentially increase synaptic and extracellular dopamine Synapse 59 2006 243 251
89. L. Sonde, M. Nordstrom, C.G. Nilsson, J. Likk, and M. Viitanen A double-blind placebo-controlled study of the effects of amphetamine and physiotherapy after stroke Cerebrovasc Dis 12 2001 235 237
90. N. Sprigg, M.R. Willmot, A. Sunderland, V. Pomeroy, M. Walker, and P.M. Bath Amphetamine increases blood pressure and heart rate but has no effect on motor recovery or cerebral haemodynamics in ischaemic stroke: a randomized controlled trial J Hum Hypertens 21 2007 616 624
91. P.G. Sullivan, A.G. Rabchevsky, P.C. Walmeier, and J.E. Springer Mitochondrial permeability transition in CNS trauma: cause or effect of neuronal cell death? J Neurosci Res 79 2005 231 239
92. G. Teasdale, and B. Jennett Assessment of coma and impaired consciousness. A practical scale Lancet 2 1974 81 84
93. The Centers for Disease Control Vietnam Experience Study Health status of Vietnam veterans JAMA 259 1988 2701 2707
94. C. Tiberti, L. Sabe, L. Jason, R. Leiguarda, and S. Starkstein A randomized double-blind placebo-controlled study of methylphenidate in patients with organic amnesia Eur J Neurol 5 1998 297 299
95. T. Treig, C. Werner, M. Sachse, and S. Hesse No benefit from d-amphetamine when added to physiotherapy after stroke: a randomized, placebo-controlled study Clin Rehabil 17 2003 590 599
96. A. Tuttolomondo, R. Di Sciacca, D. Di Raimondo, V. Arnao, C. Renda, and A. Pinto Neuron protection as a therapeutic target in acute ischemic stroke Curr Top Med Chem 9 14 2009 1317 1334
97. O. Ullrich, K. Merker, J. Timm, and S. Tauber Immune control by endocannabinoids-new mechanisms of neuroprotection? J Neuroimmunol 184 2007 127 135
98. F. Urbano, E. Leznik, and R. Llinas Modafinil enhances thalamocortical activity by increasing neuronal electronic coupling PNAS 104 2007 12554 12559
99. N.D. Volkow, J.S. Fowler, J. Logan, D. Alexoff, W. Zhu, and F. Telang Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications JAMA 301 2009 1148 1154
100. D. Walker-Batson, S. Curtis, R. Natarajan, J. Ford, N. Dronkers, and E. Salmeron A double-blind, placebo-controlled study of the use of amphetamine in the treatment of aphasia Stroke 32 2001 2093 2098
101. D.L. Warden, B. Gordon, T.W. McAllister, J.M. Silver, J.T. Barth, and J. Bruns Guidelines for the pharmacologic treatment of neurobehavioral sequelae of traumatic brain injury J Neurotrauma The NeuroTruama Foundation 23 10 2006 1468 1501
102. J. Whyte, R. Hart, Grieb-Neff P. Vaccaro, A. Risser, M. Polansky, and H.B. Coslett Effects of methylphenidate on attention deficits after traumatic brain injury: a multidimensional, randomized controlled trial Am J Phys Med Rehabil 83 2004 401 420
103. J. Whyte, M. Vaccaro, P. Grieb-Neff, and T. Hart Psychostimulant use in the rehabilitation of individuals with traumatic brain injury J Head Trauma Rehabil 17 2002 284 299
104. J. Whyte, M. Vaccaro, P. Grieb-Neff, T. Hart, M. Polansky, and H.B. Coslett The effects of bromocriptine on attention deficits after traumatic brain injury: a placebo-controlled pilot study Am J Phys Med Rehabil 87 2008 85 99
105. J. Wright The FIM(TM) The Center for Outcome Measurement in Brain Injury 2000 http://www.tbims.org/
106. J. Wright The Glasgow Outcome Scale The Center for Outcome Measurement in Brain Injury 2000 http://www.tbims.org/combi/gos (accessed November 21, 2009)
107. D.W. Wright, A.L. Kellermann, V.S. Hertzberg, P.L. Clark, M. Frankel, and F.C. Goldstein ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury Ann Emerg Med 49 2007 391 402 (402 e391-2)
108. G. Xiao, J. Wei, W. Yan, W. Wang, and Z. Lu Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: a randomized controlled trial Crit Care 12 2008 R61
109. L. Yurkewicz, J. Weaver, M.R. Bullock, and L.F. Marchall The effect of the selective NMDA receptor antagonist traxoprodil in the treatment of traumatic brain injury J Neurotrauma 22 2005 1428 1443
110. K. Zweckberger, and N. Plesnila Anatibant, a selective non-peptide bradykinin B2 receptor antagonist, reduces intracranial hypertension and histopathological damage after experimental traumatic brain injury Neurosci Lett 454 2 2009 115 117